Aerolase develops advanced medical laser systems for skin health, aesthetic care, and post-surgical recovery. Its proprietary ultra-short-pulse technology is designed to treat all Fitzpatrick skin types, including darker skin, with minimal thermal damage and essentially no downtime. The company’s FDA-cleared platforms are supported by more than 40 peer-reviewed studies and address over 30 clinical indications.
FDA-cleared devices
certification